Trial Profile
Immunogenicity of MVA 5T4 in patients with advanced colorectal cancer.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs MVA 5T4 (Primary)
- Indications Colorectal cancer
- Focus Pharmacodynamics
- Sponsors Oxford BioMedica
- 05 Nov 2010 New trial record.